BioCentury
ARTICLE | Top Story

Financing flood continues

February 23, 2000 8:00 AM UTC

Virologic (South San Francisco, Calif.), which is developing its PhenoSense viral drug resistance detection technology, filed to raise up to $75 million in an IPO. The offering will be underwritten by...